Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now includes a 2023 U.S. NIH grant/contract note. Related topic metadata now references MedlinePlus Genetics with the topic 'Multiple myeloma'.
    Difference
    0.1%
    Check dated 2026-08-25T20:39:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Removed mentions in the Related topics area: 'Multiple myeloma' and the 'MedlinePlus Genetics' entry (and the 'related topics' header). This reduces disease-specific navigation and external resource links in that section.
    Difference
    0.1%
    Check dated 2026-08-18T19:37:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The changes add the core topic 'Multiple myeloma' and include related topics such as 'MedlinePlus Genetics', enhancing the page's topic tagging and navigation. Additionally, the page revision has been updated from v3.6.4 to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-11T17:18:37.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page footer now shows a new Revision: v3.6.4, and several footer items along with the older Revision: v3.6.3 were removed. This reflects a small maintenance update to the page’s footer text rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-07-21T12:52:19.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics. The site revision was updated to v3.6.3 (replacing v3.6.0).
    Difference
    0.1%
    Check dated 2026-06-30T01:08:26.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no further participant enrollment, signaling that the study is no longer recruiting. The page also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and removes some topic labels, with the revision version updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T23:09:51.000Z thumbnail image

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.